1. 2022-RA-1540-ESGO MITO 25.1: a randomized, molecular driven phase II trial of carboplatin-paclitaxel-bevacizumab vs carboplatin-paclitaxel-bevacizumab-rucaparib vs carboplatin-paclitaxel-rucaparib, selected according to HRD status, in patients with advanced (Stage III B-C-IV) ovarian, primary peritoneal and fallopian tube cancer. (20th October 2022) Authors: Musacchio, Lucia; Salutari, Vanda; Pignata, Sandro; Valabrega, Giorgio; Zavallone, Laura; Cormio, Gennaro; Mosconi, Anna Maria; Giolitto, Serena; Giudice, Elena; Ricci, Caterina; Zamagni, Claudio; Nero, Camilla; Carbone, Maria Vittoria; Ghizzoni, Viola; Sorio, Roberto; Siena, Salvatore; Tronconi,... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-1638-ESGO Randomized phase III trial on Niraparib-TSR-042 (dostarlimab) versus physician's choice in recurrent ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33). (20th October 2022) Authors: Salutari, Vanda; Musacchio, Lucia; Pignata, Sandro; Braicu, Elena; Cibula, David; Colombo, Nicoletta; Frenel, Jean Sebastien; Giolitto, Serena; Camarda, Floriana; Perri, Maria Teresa; Giudice, Elena; Scambia, Giovanni; Lorusso, Domenica Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A common pattern of somatic mutations in t‐MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer. Issue 11 (8th September 2022) Authors: Chiusolo, Patrizia; Marchetti, Claudia; Rossi, Monica; Minnella, Gessica; Salutari, Vanda; Distefano, Mariagrazia; Giammarco, Sabrina; Metafuni, Elisabetta; Minucci, Angelo; Frioni, Filippo; Gasbarrino, Cristiana; Colangelo, Maria; Orteschi, Daniela; Fagotti, Anna; Lorusso, Domenica; Pagano, Livi... Journal: American journal of hematology Issue: Volume 97:Issue 11(2022) Page Start: E400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A retrospective analysis of trabectedin infusion by peripherally inserted central venous catheters. Issue 9 (October 2015) Authors: Martella, Francesca; Salutari, Vanda; Marchetti, Claudia; Pisano, Carmela; Di Napoli, Marilena; Pietta, Francesca; Centineo, Dina; Caringella, Anna M.; Musella, Angela; Fioretto, Luisa Journal: Anti-cancer drugs Issue: Volume 26:Issue 9(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A retrospective analysis of trabectedin infusion by peripherally inserted central venous catheters: a multicentric Italian experience. Issue 9 (October 2015) Authors: Martella, Francesca; Salutari, Vanda; Marchetti, Claudia; Pisano, Carmela; Di Napoli, Marilena; Pietta, Francesca; Centineo, Dina; Caringella, Anna M.; Musella, Angela; Fioretto, Luisa Journal: Anti-cancer drugs Issue: Volume 26:Issue 9(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Advanced and recurrent endometrial cancer: State of the art and future perspectives. (December 2022) Authors: Tronconi, Francesca; Nero, Camilla; Giudice, Elena; Salutari, Vanda; Musacchio, Lucia; Ricci, Caterina; Carbone, Maria Vittoria; Ghizzoni, Viola; Perri, Maria Teresa; Camarda, Floriana; Gentile, Marica; Berardi, Rossana; Scambia, Giovanni; Lorusso, Domenica Journal: Critical reviews in oncology/hematology Issue: Volume 180(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study. Issue 6 (30th April 2021) Authors: Daniele, Gennaro; Raspagliesi, Francesco; Scambia, Giovanni; Pisano, Carmela; Colombo, Nicoletta; Frezzini, Simona; Tognon, Germana; Artioli, Grazia; Gadducci, Angiolo; Lauria, Rossella; Ferrero, Annamaria; Cinieri, Saverio; De Censi, Andrea; Breda, Enrico; Scollo, Paolo; De Giorgi, Ugo; Lissoni,... Journal: International journal of gynecological cancer Issue: Volume 31:Issue 6(2021) Page Start: 875 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO‐16A/MaNGO‐OV2A study. Issue 6 (June 2021) Authors: Daniele, Gennaro; Raspagliesi, Francesco; Scambia, Giovanni; Pisano, Carmela; Colombo, Nicoletta; Frezzini, Simona; Tognon, Germana; Artioli, Grazia; Gadducci, Angiolo; Lauria, Rossella; Ferrero, Annamaria; Cinieri, Saverio; De Censi, Andrea; Breda, Enrico; Scollo, Paolo; De Giorgi, Ugo; Lissoni,... Journal: International journal of gynecological cancer Issue: Volume 31:Issue 6(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial. Issue 3 (March 2023) Authors: Pignata, Sandro; Scambia, Giovanni; Schettino, Clorinda; Arenare, Laura; Pisano, Carmela; Lombardi, Davide; De Giorgi, Ugo; Andreetta, Claudia; Cinieri, Saverio; De Angelis, Carmine; Priolo, Domenico; Casanova, Claudia; Rosati, Marta; Greco, Filippo; Zafarana, Elena; Schiavetto, Ilaria; Mammoliti... Journal: Lancet oncology Issue: Volume 24:Issue 3(2023) Page Start: 286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial. Issue 2 (February 2021) Authors: Pignata, Sandro; Lorusso, Domenica; Joly, Florence; Gallo, Ciro; Colombo, Nicoletta; Sessa, Cristiana; Bamias, Aristotelis; Salutari, Vanda; Selle, Frédèric; Frezzini, Simona; De Giorgi, Ugo; Pautier, Patricia; Bologna, Alessandra; Orditura, Michele; Dubot, Coraline; Gadducci, Angiolo; Mammoliti,... Journal: Lancet oncology Issue: Volume 22:Issue 2(2021) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗